These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 27475333)
1. The economic burden of methicillin-resistant Staphylococcus aureus in community-onset pneumonia inpatients. Uematsu H; Yamashita K; Kunisawa S; Fushimi K; Imanaka Y Am J Infect Control; 2016 Dec; 44(12):1628-1633. PubMed ID: 27475333 [TBL] [Abstract][Full Text] [Related]
2. Estimating the disease burden of methicillin-resistant Staphylococcus aureus in Japan: Retrospective database study of Japanese hospitals. Uematsu H; Yamashita K; Kunisawa S; Fushimi K; Imanaka Y PLoS One; 2017; 12(6):e0179767. PubMed ID: 28654675 [TBL] [Abstract][Full Text] [Related]
3. Comparing methods to estimate incremental inpatient costs and length of stay due to methicillin-resistant Staphylococcus aureus in Alberta, Canada. Kirwin E; Varughese M; Waldner D; Simmonds K; Joffe AM; Smith S BMC Health Serv Res; 2019 Oct; 19(1):743. PubMed ID: 31651305 [TBL] [Abstract][Full Text] [Related]
4. In-hospital mortality associated with community-acquired pneumonia due to methicillin-resistant Staphylococcus aureus: a matched-pair cohort study. Sakamoto Y; Yamauchi Y; Jo T; Michihata N; Hasegawa W; Takeshima H; Matsui H; Fushimi K; Yasunaga H; Nagase T BMC Pulm Med; 2021 Nov; 21(1):345. PubMed ID: 34732194 [TBL] [Abstract][Full Text] [Related]
5. [Impact on morbidity and costs of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in intensive care patients]. Larue A; Loos-Ayav C; Jay N; Commun N; Rabaud C; Bollaert PE Presse Med; 2009 Jan; 38(1):25-33. PubMed ID: 18771897 [TBL] [Abstract][Full Text] [Related]
6. Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia. Jung WJ; Kang YA; Park MS; Park SC; Leem AY; Kim EY; Chung KS; Kim YS; Kim SK; Chang J; Jung JY BMC Infect Dis; 2013 Aug; 13():370. PubMed ID: 23937553 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia. Wooten DA; Winston LG Respir Med; 2013 Aug; 107(8):1266-70. PubMed ID: 23756035 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of methicillin-resistant Staphylococcus aureus pneumonia in community hospitals. Lewis SS; Walker VJ; Lee MS; Chen L; Moehring RW; Cox CE; Sexton DJ; Anderson DJ Infect Control Hosp Epidemiol; 2014 Dec; 35(12):1452-7. PubMed ID: 25419766 [TBL] [Abstract][Full Text] [Related]
10. Costs of nosocomial pneumonia caused by meticillin-resistant Staphylococcus aureus. Ott E; Bange FC; Reichardt C; Graf K; Eckstein M; Schwab F; Chaberny IF J Hosp Infect; 2010 Dec; 76(4):300-3. PubMed ID: 20951471 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology and outcome of invasive fungal infections and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia and complicated skin and soft tissue infections (cSSTI) in Lebanon and Saudi Arabia. Moghnieh R; Alothman AF; Althaqafi AO; Matar MJ; Alenazi TH; Farahat F; Corman SL; Solem CT; Raghubir N; Macahilig C; Stephens JM J Infect Public Health; 2017; 10(6):849-854. PubMed ID: 28487208 [TBL] [Abstract][Full Text] [Related]
12. A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia. Shorr AF; Myers DE; Huang DB; Nathanson BH; Emons MF; Kollef MH BMC Infect Dis; 2013 Jun; 13():268. PubMed ID: 23742753 [TBL] [Abstract][Full Text] [Related]
13. Burden of meticillin-resistant Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs. Macedo-ViƱas M; De Angelis G; Rohner P; Safran E; Stewardson A; Fankhauser C; Schrenzel J; Pittet D; Harbarth S J Hosp Infect; 2013 Jun; 84(2):132-7. PubMed ID: 23608003 [TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children's Hospital. Carrillo-Marquez MA; Hulten KG; Hammerman W; Lamberth L; Mason EO; Kaplan SL Pediatr Infect Dis J; 2011 Jul; 30(7):545-50. PubMed ID: 21407143 [TBL] [Abstract][Full Text] [Related]
15. Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections. Lessa FC; Mu Y; Ray SM; Dumyati G; Bulens S; Gorwitz RJ; Fosheim G; DeVries AS; Schaffner W; Nadle J; Gershman K; Fridkin SK; ; Clin Infect Dis; 2012 Jul; 55(2):232-41. PubMed ID: 22523264 [TBL] [Abstract][Full Text] [Related]
16. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Shorr AF; Tabak YP; Gupta V; Johannes RS; Liu LZ; Kollef MH Crit Care; 2006; 10(3):R97. PubMed ID: 16808853 [TBL] [Abstract][Full Text] [Related]
17. Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study. Shorr AF; Zilberberg MD; Micek ST; Kollef MH Crit Care; 2015 Sep; 19(1):312. PubMed ID: 26335247 [TBL] [Abstract][Full Text] [Related]
18. Management of methicillin-resistant Staphylococcus aureus pneumonia. Luna CM; Boyeras Navarro ID Curr Opin Infect Dis; 2010 Apr; 23(2):178-84. PubMed ID: 20075728 [TBL] [Abstract][Full Text] [Related]
19. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection? Ben-David D; Novikov I; Mermel LA Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of methicillin-resistant staphylococcus aureus as an etiology of community-acquired pneumonia. Moran GJ; Krishnadasan A; Gorwitz RJ; Fosheim GE; Albrecht V; Limbago B; Talan DA; Clin Infect Dis; 2012 Apr; 54(8):1126-33. PubMed ID: 22438343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]